Chimerix to Announce First Quarter 2017 Financial Results on May 9, 2017
May 02, 2017 12:02 pm UTC| Business
DURHAM, N.C., May 02, 2017 -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company discovering, developing and commercializing medicines that improve outcomes for immunocompromised patients,today announced that it...
Inovio Pharmaceuticals to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference
May 02, 2017 12:02 pm UTC| Business
PLYMOUTH MEETING, Pa., May 02, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it will participate in the Bank of America Merrill Lynch 2017 Healthcare Conference May 16-18th, 2017 in Las Vegas,...
Inovio Pharmaceuticals to Participate in Bank of America Merrill Lynch 2017 Healthcare Conference
May 02, 2017 12:02 pm UTC| Business
PLYMOUTH MEETING, Pa., May 02, 2017 -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it will participate in the Bank of America Merrill Lynch 2017 Healthcare Conference May 16-18th, 2017 in Las Vegas,...
21Vianet Group, Inc. to Announce First Quarter 2017 Financial Results
May 02, 2017 12:02 pm UTC| Business
BEIJING, May 02, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its first...
21Vianet Group, Inc. to Announce First Quarter 2017 Financial Results
May 02, 2017 12:02 pm UTC| Business
BEIJING, May 02, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its first...
21Vianet Group, Inc. to Announce First Quarter 2017 Financial Results
May 02, 2017 12:02 pm UTC| Business
BEIJING, May 02, 2017 -- 21Vianet Group, Inc. (Nasdaq:VNET) (“21Vianet” or the “Company”), a leading carrier-neutral Internet data center services provider in China, today announced that it plans to release its first...
Momenta Pharmaceuticals Reports First Quarter 2017 Financial Results
May 02, 2017 12:01 pm UTC| Business
--Company reports Glatopa® 20 mg product revenues of $23 million, a 58% increase over the same period in 2016-- --Ended the first quarter with a strong cash position of $434 million--CAMBRIDGE, Mass., May 02, 2017 --...
Trump Floats Greenland Framework, Bets Big on ‘Mission 500’ With India